Strata Critical Medical, Inc.

SRTA - Financial Snapshot

Metrics for SRTA

Price $5.57
Shares Outstanding 86.37M

Balance Statement Metrics

Net Cash / Share $0.28
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $0.82
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $1.72
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding

Income Metrics

Max Earning Power / Share $-0.43
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $6.33
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 0.34%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 01-14-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 12-21-2025
Income indicators Value Date
EBITDA Positive No 12-21-2025
Net Income Positive Yes 12-21-2025
Avg CA Burn (Annual %) -17.85% 12-21-2025
Avg CA Burn (Quarterly %) -7.66% 12-21-2025

Shares Outstanding Changes

Date Shares Outstanding Delta
No recent share changes

Interesting Volume Days

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.